CD56 anticorps (FITC)

N° du produit ABIN7178523

L’anticorps Souris Monoclonal anti-CD56 a été validé pour FACS, IF et ELISA. Il convient pour détecter CD56 dans des échantillons de Humain.

Aperçu rapide pour CD56 anticorps (FITC) (ABIN7178523)

Antigène: CD56 (NCAM1) (Neural Cell Adhesion Molecule 1 (NCAM1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD56 est conjugé à/à la FITC

Application: Flow Cytometry (FACS), Immunofluorescence (IF), ELISA

Détail du produit anti-CD56 anticorps (FITC)

Fonction: NCAM1 Monoclonal Antibody,FITC Conjugated

Purification: Affinity purified

Immunogène: Recombinant Protein

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Phosphate-buffered solution, pH 7.4, containing 0.09 % sodium azide and 0.2 % (w/v) BSA

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur CD56

Antigène: CD56 (NCAM1) (Neural Cell Adhesion Molecule 1 (NCAM1))

Autre désignation: NCAM1

Sujet:

Background: COC56 reacts with CD56, a 175-220 kDa Neural Cell Adhesion Molecule (NCAM), expressed on 10-25% of peripheral blood lymphocytes, including all CD16+ NK cells and approximately 5% of CD3+ lymphocytes, referred to as NKT cells. It also is present at brain and neuromuscular junctions, certain LGL leukemias, small cell lung carcinomas, neuronally derived tumors, myeloma and myeloid leukemias. CD56 (NCAM) is involved in neuronal homotypic cell adhesion which is implicated in neural development, and in cell differentiation during embryogenesis.1. Knapp, W et al., eds. (1989) Leucocyte Typing  IV: White Cell Differentiation Antigens, Oxford University Press, New York.2. Lanier LL . et al. (1991)  J. Immunol. 146:4421-4426.3. Campbell, JJ et al. (2001) J. Immunol . 166:6477-6482.4. Cooper MD  et al. (2001)  Trends in Immunol. 22:633-640.5. Galandrini R  et al. (2002)  Blood. 100:4581-4589.

Aliases: N/A

UniProt: P13591